Patents by Inventor Alexis Brice

Alexis Brice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
    Patent number: 7070940
    Abstract: The present invention relates to a method for determining the ability of a compound to modify the interaction between parkin and the p38 protein, and in particular to a method for screening for or detecting compounds intended for the prevention and/or treatment of neurodegenerative pathological conditions. The present inventions also relates to compounds identified in the above screening method.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: July 4, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Olga Corti, Cornelia Hampe, Alexis Brice, Laurent Pradier, Thomas Rooney, Alain Fournier
  • Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
    Publication number: 20040214763
    Abstract: The present invention relates to a method for determining the ability of a compound to modify the interaction between parkin and the p38 protein, and in particular to a method for screening for or detecting compounds intended for the prevention and/or treatment of neurodegenerative pathological conditions.
    Type: Application
    Filed: July 18, 2003
    Publication date: October 28, 2004
    Applicants: Aventis Pharma, S.A., L'Institue Nat'l Santa Recherche Medicale
    Inventors: Olga Corti, Cornelia Hampe, Alexis Brice, Laurent Pradier, Thomas Rooney, Alain Fournier
  • Compositions which can be used for regulating the activity of parkin
    Publication number: 20020155577
    Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.
    Type: Application
    Filed: February 20, 2001
    Publication date: October 24, 2002
    Inventors: Hana Koutnikova, Alexis Brice, Alain Fournier, Laurent Pradier, Catherine Prades, Isabelle Arnould-Reguigne, Marie-Francoise Rosier-Montus, Olga Corti